Clinical Trials Browser

Phase 2 × Has results × aflibercept × Clear all

NCT03712904 2025-09-24

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Phase 2 Terminated

3 enrolled 9 charts

Uveal Melanoma

NCT01652196 2025-02-05

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Phase 2 Completed

56 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02384759 2024-07-10

FOLFA

Phase 2 Completed

117 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT00407654 2024-03-04

VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Phase 2 Completed

75 enrolled 15 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01782443 2023-08-14

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

Phase 2 Completed

19 enrolled 11 charts

Carcinoid Tumor, Neoplasm Metastasis

NCT02181556 2021-06-07

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

Phase 2 Completed

41 enrolled 8 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02340949 2021-05-03

RIA

Phase 2 Completed

180 enrolled 15 charts

Gastrointestinal

Rectal Neoplasms

NCT02101918 2020-03-23

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Phase 2 Completed

22 enrolled 10 charts

Somatostatinoma, Multiple Endocrine Neoplasia Type 1

NCT01669720 2020-02-17

C261

Phase 2 Terminated

10 enrolled 7 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01747551 2020-02-10

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Phase 2 Completed

64 enrolled 11 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT00462826 2019-07-23

VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

49 enrolled 13 charts

Endometrial Neoplasms

NCT01258855 2019-05-10

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

84 enrolled 13 charts

Melanoma

NCT00450255 2018-05-24

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

41 enrolled 7 charts

Uveal Melanoma, Melanoma

NCT00828139 2017-08-21

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

189 enrolled 15 charts

Small Cell Lung Carcinoma

NCT00357760 2017-06-23

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

94 enrolled 8 charts

Carcinoma, Renal Cell

NCT01882868 2017-03-14

A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

Phase 2 Completed

62 enrolled 34 charts

Gastrointestinal

Colorectal Cancer Metastatic

NCT01749956 2017-02-07

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

Phase 2 Completed

39 enrolled 13 charts

Gastrointestinal

Rectal Neoplasms

NCT00851084 2016-06-07

AFFIRM

Phase 2 Completed

268 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00390234 2015-12-07

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Phase 2 Completed

63 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00509249 2015-01-08

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Phase 2 Terminated

18 enrolled 4 charts

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00407485 2014-10-20

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

Phase 2 Completed

22 enrolled 7 charts

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00396591 2013-01-10

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Phase 2 Completed

16 enrolled 18 charts

Ovarian Neoplasms

NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase 2 Completed

98 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms